Platelet microparticles are heterogeneous and highly dependent on the activation mechanism: Studies using a new digital flow cytometer

被引:128
作者
Perez-Pujol, Silvia
Marker, Paul H.
Key, Nigel S.
机构
[1] Univ N Carolina, Dept Med, Div Hematol & Oncol, Chapel Hill, NC 27599 USA
[2] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA
关键词
platelet; microparticle; sorting; flow cytometry; phosphatidylserine;
D O I
10.1002/cyto.a.20354
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background: Platelet-derived microparticles (MPs) are believed to play an important role in coagulation and inflammatory disorders. Unfortunately, MP size renders them difficult to study and analyze by conventional flow cytometry. Methods: We analyzed and characterized platelet-derived MPs, using antibodies against the major surface glycoproteins (GP), the platelet activation antigen P-selectin (CD62P), and a marker of procoagulant activity (phosphatidylserine exposure). MPs were generated by exposure of platelets to thrombin receptor activating peptide (TRAP) or ionophore. Both agonists induced significant microvesiculation of platelets, and the resulting MPs were analyzed by a new digital flow cytometer: Becton-Dickinson FACSAria (TM). Results: Membrane GPs were equally well represented in MPs generated by either reagent. In contrast, P-selectin was more intensely expressed in TRAP-MPs, while phosphatidylserine (PS) expression was markedly increased in ionophore-MPs. Two distinct populations of TRAP-MPs (one PS-positive and another PS-negative) were apparent. The latter characteristic facilitated sorting of MPs according to their PS exposure. Conclusions: The data presented herein show a significant improvement in the methodology applied until now to the characterization of MPs. The ability to characterize and sort MP subpopulations may help to resolve their contributions to normal and pathological functions. (c) 2007 International Society for Analytical Cytology
引用
收藏
页码:38 / 45
页数:8
相关论文
共 27 条
[1]   Circulating platelet-derived microparticles with procoagulant activity may be a potential cause of thrombosis in uremic patients [J].
Ando, M ;
Iwata, A ;
Ozeki, Y ;
Tsuchiya, K ;
Akiba, T ;
Nihei, H .
KIDNEY INTERNATIONAL, 2002, 62 (05) :1757-1763
[2]  
Berckmans RJ, 2001, THROMB HAEMOSTASIS, V85, P639
[3]   CHANGES IN MEMBRANE PHOSPHOLIPID DISTRIBUTION DURING PLATELET ACTIVATION [J].
BEVERS, EM ;
COMFURIUS, P ;
ZWAAL, RFA .
BIOCHIMICA ET BIOPHYSICA ACTA, 1983, 736 (01) :57-66
[4]  
Bode AP, 2000, PLATELETS, V11, P259
[5]   Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction [J].
Boulanger, CM ;
Scoazec, A ;
Ebrahimian, T ;
Henry, P ;
Mathieu, E ;
Tedgui, A ;
Mallat, Z .
CIRCULATION, 2001, 104 (22) :2649-2652
[6]   Physiopathological significance of catalytic phospholipids in the generation of thrombin [J].
DacharyPrigent, J ;
Toti, F ;
Satta, N ;
Pasquet, JM ;
Uzan, A ;
Freyssinet, JM .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1996, 22 (02) :157-164
[7]   CALCIUM INVOLVEMENT IN AMINOPHOSPHOLIPID EXPOSURE AND MICROPARTICLE FORMATION DURING PLATELET ACTIVATION - A STUDY USING CA2+-ATPASE INHIBITORS [J].
DACHARYPRIGENT, J ;
PASQUET, JM ;
FREYSSINET, JM ;
NURDEN, AT .
BIOCHEMISTRY, 1995, 34 (36) :11625-11634
[8]  
DACHARYPRIGENT J, 1993, BLOOD, V81, P2554
[9]   Phenotypic assessment of endothelial microparticles in patients with heart failure and after heart transplantation:: Switch from cell activation to apoptosis [J].
Garcia, S ;
Chirinos, J ;
Jimenez, J ;
Muñoz, FD ;
Canoniero, M ;
Jy, W ;
Jimenez, J ;
Horstman, L ;
Ahn, Y .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (12) :2184-2189
[10]   Glycoprotein IIb-IIIa on platelet-derived microparticles, and microparticle structures studied by electron microscopy, confocal laser microscopy and crossed radio-immunoelectrophoresis [J].
Holme, PA ;
Roger, M ;
Solum, NO ;
Brosstad, F ;
Larsen, AM ;
Hovig, T .
PLATELETS, 1996, 7 (04) :207-214